Enhancer of zeste homolog 2 facilitates phenotypic transition of vascular smooth muscle cells leading to aortic aneurysm/dissection

Shishan Xue,Shuai Leng,Fengquan Zhang,Zhiqiao Dang,Guohai Su,Wenqian Yu
DOI: https://doi.org/10.3892/etm.2024.12433
IF: 2.7
2024-02-19
Experimental and Therapeutic Medicine
Abstract:Thoracic aortic aneurysms (TAAs) are a major cause of death owing to weaker blood vessel walls and higher rupture rates in affected individuals. Vascular smooth muscle cells (VSMCs) are the predominant cell type within the aortic wall and their dysregulation may contribute to TAA progression. Enhancer of zeste homolog 2 (EZH2), a histone methyltransferase, is involved in several pathological processes; however, the biological functions and mechanisms underlying VSMC phenotype transition and vascular intimal hyperplasia remain unclear. The present study aimed to determine the involvement of EZH2 in mediating VSMC function in the development of TAAs. The expression of EZH2 was revealed to be elevated in patients with thoracic aortic dissection and TAA mouse model through western blotting and reverse transcription-quantitative PCR experiments. Subsequently, a mouse model was established using β-aminopropionitrile. <i>In vitro</i>, EdU labeling, Transwell assay, wound healing assay and hematoxylin-eosin staining revealed that knocking down the <i>Ezh2</i> gene could reduce the proliferation, invasion, migration, and calcification of mouse primary aortic smooth muscle cells. Flow cytometry analysis found that EZH2 deficiency increased cell apoptosis. Depletion of <i>Ezh2</i> in mouse primary aortic VSMCs promoted the transformation of VSMCs from a synthetic to a contractile phenotype. Using RNA-sequencing analysis, it was demonstrated that <i>Ezh2</i> regulated a group of genes, including integrin β3 (<i>Itgb3</i>), which are critically involved in the extracellular matrix signaling pathway. qChIP found <i>Ezh2</i> occupies the <i>Itgb3</i> promoter, thereby suppressing the expression of <i>Itgb3</i>. <i>Ezh2</i> promotes the invasion and calcification of VSMCs, and this promoting effect is partially reversed by co-knocking down <i>Itgb3</i>. In conclusion, the present study identified a previously unrecognized EZH2-ITGB3 regulatory axis and thus provides novel mechanistic insights into the pathophysiological function of EZH2. EZH2 may thus serve as a potential target for the management of TAAs.
medicine, research & experimental
What problem does this paper attempt to address?